Anti-Helicobacter pylori activity and Structure-Activity Relationship study of 2-Alkylthio-5-(nitroaryl)-1,3,4-thiadiazole Derivatives.

PubWeight™: 0.96‹?› | Rank: Top 15%

🔗 View Article (PMC 3813270)

Published in Iran J Pharm Res on January 01, 2013

Authors

Ali Asadipour1, Najmeh Edraki, Maryam Nakhjiri, Azadeh Yahya-Meymandi, Eskandar Alipour, Parastoo Saniee, Farideh Siavoshi, Abbas Shafiee, Alireza Foroumadi

Author Affiliations

1: Department of Medicinal Chemistry, Faculty of Pharmacy and Neuroscience Research Center, Kerman University of Medical Sciences, Kerman, Iran.

Articles cited by this

Regression of primary gastric lymphoma of mucosa-associated lymphoid tissue type after cure of Helicobacter pylori infection. MALT Lymphoma Study Group. Lancet (1995) 6.32

Nitroimidazole drugs--action and resistance mechanisms. I. Mechanisms of action. J Antimicrob Chemother (1993) 3.24

Condensed bridgehead nitrogen heterocyclic system: synthesis and pharmacological activities of 1,2,4-triazolo-[3,4-b]-1,3,4-thiadiazole derivatives of ibuprofen and biphenyl-4-yloxy acetic acid. Eur J Med Chem (2007) 1.55

Synthesis, antimicrobial and cytotoxic activities of 1,3,4-oxadiazoles, 1,3,4-thiadiazoles and 1,2,4-triazoles. Eur J Med Chem (2008) 1.53

Helicobacter pylori and gastric cancer. Lancet (1994) 1.37

Helicobacter pylori: an invading microorganism? A review. FEMS Immunol Med Microbiol (2003) 1.25

Antibacterial activity of hydrolyzable tannins derived from medicinal plants against Helicobacter pylori. Microbiol Immunol (2004) 1.24

Universal high-level primary metronidazole resistance in Helicobacter pylori isolated from children in Egypt. J Clin Microbiol (2004) 1.19

In vitro anti-Helicobacter pylori activity of extracts of selected medicinal plants from North West Cameroon. J Ethnopharmacol (2007) 1.12

Evolution of Helicobacter pylori therapy from a meta-analytical perspective. Helicobacter (2007) 1.07

Treatment of Helicobacter pylori infection: the past and the future. Eur J Intern Med (2010) 1.02

Helicobacter pylori and gastric malignancies. Helicobacter (2002) 1.02

Anti-Helicobacter pylori activities of six Iranian plants. Helicobacter (2004) 0.98

In vitro antibacterial activity of some Iranian medicinal plant extracts against Helicobacter pylori. Nat Prod Res (2011) 0.95

Synthesis, selective anti-Helicobacter pylori activity, and cytotoxicity of novel N-substituted-2-oxo-2H-1-benzopyran-3-carboxamides. Bioorg Med Chem Lett (2010) 0.93

Oral broccoli sprouts for the treatment of Helicobacter pylori infection: a preliminary report. Dig Dis Sci (2004) 0.91

Nitroimidazoles as chemotherapeutic agents. Prog Drug Res (1983) 0.90

Synthesis and antileishmanial activity of novel 5-(5-nitrofuran-2-y1)-1,3,4-thiadiazoles with piperazinyl-linked benzamidine substituents. Eur J Med Chem (2011) 0.89

Helicobacter pylori: current chemotherapy and new targets for drug design. Curr Pharm Des (2001) 0.86

5-Nitroimidazole-based 1,3,4-thiadiazoles: heterocyclic analogs of metronidazole as anti-Helicobacter pylori agents. Arch Pharm (Weinheim) (2010) 0.85

Treatment of H. pylori infection: a review. Curr Med Chem (2005) 0.83

Antibacterial agents (oxazolidinones, quinolones, macrolides and new agents): patent highlights June to December 2000. Curr Opin Investig Drugs (2001) 0.79

Synthesis and antileishmanial activity of 5-(5-nitroaryl)-2-substituted-thio-1,3,4-thiadiazoles. J Enzyme Inhib Med Chem (2010) 0.78

Articles by these authors

Design, synthesis, and biological evaluation of substituted 3-alkylthio-4,5-diaryl-4H-1,2,4-triazoles as selective COX-2 inhibitors. Bioorg Med Chem (2005) 1.89

Synthesis and anticonvulsant activity of new 2-substituted-5- [2-(2-fluorophenoxy)phenyl]-1,3,4-oxadiazoles and 1,2,4-triazoles. Bioorg Med Chem Lett (2004) 1.82

Synthesis and antibacterial activity of 1-[1,2,4-triazol-3-yl] and 1-[1,3,4-thiadiazol-2-yl]-3-methylthio-6,7-dihydrobenzo[c]thiophen-4(5H)ones. Bioorg Med Chem Lett (2005) 1.64

Could Helicobacter pylori play an important role in axonal type of Guillain-Barré syndrome pathogenesis? Clin Neurol Neurosurg (2009) 1.42

Synthesis and antibacterial activity of levofloxacin derivatives with certain bulky residues on piperazine ring. Eur J Med Chem (2007) 1.40

Synthesis and anticonvulsant activity of new 2-substituted-5-(2-benzyloxyphenyl)-1,3,4-oxadiazoles. Bioorg Med Chem Lett (2005) 1.36

Thiazolyl N-benzyl-substituted acetamide derivatives: synthesis, Src kinase inhibitory and anticancer activities. Eur J Med Chem (2011) 1.26

Nitroimidazolyl-1,3,4-thiadiazole-based anti-leishmanial agents: synthesis and in vitro biological evaluation. Eur J Med Chem (2008) 1.25

Structural features of new quinolones and relationship to antibacterial activity against Gram-positive bacteria. Mini Rev Med Chem (2006) 1.19

2-Hydroxyphenacyl azoles and related azolium derivatives as antifungal agents. Bioorg Med Chem Lett (2007) 1.17

Phytochemical investigation and anti-inflammatory activity of aerial parts of Stachys byzanthina C. Koch. J Ethnopharmacol (2005) 1.16

Synthesis and analgesic activity of 2-phenoxybenzoic acid and N-phenylanthranilic acid hydrazides. Biol Pharm Bull (2006) 1.16

Umbelliprenin from Ferula persica roots inhibits the red pigment production in Serratia marcescens. Z Naturforsch C (2005) 1.14

Antidiabetic effect of Phlomis anisodonta: effects on hepatic cells lipid peroxidation and antioxidant enzymes in experimental diabetes. Pharmacol Res (2007) 1.13

Design and synthesis of 4H-3-(2-phenoxy)phenyl-1,2,4-triazole derivatives as benzodiazepine receptor agonists. Bioorg Med Chem (2003) 1.12

Synthesis and biological evaluation of 2-phenylthiazole-4-carboxamide derivatives as anticancer agents. Eur J Med Chem (2010) 1.11

Bioactive compounds of the volatile oil of Dracocephalum kotschyi. Z Naturforsch C (2008) 1.11

Design and synthesis of new 2-substituted-5-(2-benzylthiophenyl)-1,3,4-oxadiazoles as benzodiazepine receptor agonists. Bioorg Med Chem Lett (2005) 1.10

Design and synthesis of new 2-substituted-5-[2-(2-halobenzyloxy)phenyl]-1,3,4-oxadiazoles as anticonvulsant agents. Chem Pharm Bull (Tokyo) (2008) 1.09

Childhood hygienic practice and family education status determine the prevalence of Helicobacter pylori infection in Iran. Helicobacter (2009) 1.08

Stereoselective synthesis and in vitro antifungal evaluation of (E)- and (Z)-imidazolylchromanone oxime ethers. Arch Pharm (Weinheim) (2002) 1.08

Concomitant activation of caspase-9 and down-regulation of IAP proteins as a mechanism of apoptotic death in HepG2, T47D and HCT-116 cells upon exposure to a derivative from 4-aryl-4H-chromenes family. Biomed Pharmacother (2011) 1.04

Stereoselective synthesis and antifungal activity of (Z)-trans-3-azolyl-2-methylchromanone oxime ethers. Bioorg Med Chem (2004) 1.04

Synthesis and analgesic activity of N-Arylhydrazone derivatives of mefenamic acid. J Pharm Pharm Sci (2005) 1.03

Large-scale virtual screening for the identification of new Helicobacter pylori urease inhibitor scaffolds. J Mol Model (2011) 1.02

Increase in resistance rates of H. pylori isolates to metronidazole and tetracycline--comparison of three 3-year studies. Arch Iran Med (2010) 1.01

Low Helicobacter pylori eradication rates with 4- and 7-day regimens in an Iranian population. J Gastroenterol Hepatol (2003) 1.00

Antiproliferative activity of flavonoids: influence of the sequential methoxylation state of the flavonoid structure. Phytother Res (2011) 0.99

Ethnic and geographic differentiation of Helicobacter pylori within Iran. PLoS One (2010) 0.98

miRNAs expressed differently in cancer stem cells and cancer cells of human gastric cancer cell line MKN-45. Cell Biochem Funct (2012) 0.97

Synthesis and In vitro cytotoxic activity evaluation of (E)-16-(substituted benzylidene) derivatives of dehydroepiandrosterone. Daru (2013) 0.97

Helicobacter pylori reinfection rate 3 years after successful eradication. J Gastroenterol Hepatol (2005) 0.96

Synthesis and cytotoxic properties of novel (E)-3-benzylidene-7-methoxychroman-4-one derivatives. Daru (2013) 0.95

Asymmetrical 2,6-bis(benzylidene)cyclohexanones: Synthesis, cytotoxic activity and QSAR study. Eur J Med Chem (2012) 0.95

Synthesis of carbon-14 analogue of 1,5 diaryl-5-[14C]-1,2,3-triazoles. Appl Radiat Isot (2004) 0.95

Synthesis and biological evaluation of 3-(trimethoxyphenyl)-2(3H)-thiazole thiones as combretastatin analogs. Eur J Med Chem (2013) 0.94

Synthesis and antioxidant properties of substituted 3-benzylidene-7-alkoxychroman-4-ones. Bioorg Med Chem Lett (2007) 0.93

Design, synthesis and anticholinesterase activity of a novel series of 1-benzyl-4-((6-alkoxy-3-oxobenzofuran-2(3H)-ylidene) methyl) pyridinium derivatives. Bioorg Med Chem (2010) 0.93

Effect of Phlomis persica on glucose levels and hepatic enzymatic antioxidants in streptozotocin-induced diabetic rats. Pharmacogn Mag (2010) 0.93

New approach to bone tissue engineering: simultaneous application of hydroxyapatite and bioactive glass coated on a poly(L-lactic acid) scaffold. ACS Appl Mater Interfaces (2011) 0.92

Synthesis and in vitro evaluation of novel 1,2,4-triazine derivatives as neuroprotective agents. Bioorg Med Chem (2010) 0.92

Effects of low level laser therapy on proliferation and neurotrophic factor gene expression of human schwann cells in vitro. J Photochem Photobiol B (2011) 0.92

N-Substituted piperazinyl quinolones as potential cytotoxic agents: structure-activity relationships study. Biomed Pharmacother (2008) 0.91

Iran's scientists condemn instances of plagiarism. Nature (2009) 0.90

Design of conformationally constrained azole antifungals: efficient synthesis and antifungal activity of trans-3-imidazolylflavanones. Chem Biol Drug Des (2009) 0.90

(E)- and (Z)-1,2,4-triazolylchromanone oxime ethers as conformationally constrained antifungals. Bioorg Med Chem (2004) 0.90

Synthesis and antileishmanial activity of novel 5-(5-nitrofuran-2-y1)-1,3,4-thiadiazoles with piperazinyl-linked benzamidine substituents. Eur J Med Chem (2011) 0.89

Quantification of endogenous steroids in human urine by gas chromatography mass spectrometry using a surrogate analyte approach. J Chromatogr B Analyt Technol Biomed Life Sci (2010) 0.89

Design, synthesis, and calcium channel antagonist activity of new 1,4-dihydropyridines containing 4-(5)-chloro-2-ethyl-5-(4)-imidazolyl substituent. Arch Pharm (Weinheim) (2006) 0.89

Radioprotective effects of citrus extract against gamma-irradiation in mouse bone marrow cells. J Radiat Res (2003) 0.89

Synthesis and antiproliferative activity evaluation of imidazole-based indeno[1,2-b]quinoline-9,11-dione derivatives. Arch Pharm Res (2013) 0.89

Poly (epsilon-caprolactone) nanofibrous ring surrounding a polyvinyl alcohol hydrogel for the development of a biocompatible two-part artificial cornea. Int J Nanomedicine (2011) 0.88

A new strategy based on pharmacophore-based virtual screening in adenosine deaminase inhibitors detection and in-vitro study. Daru (2012) 0.88

Design, Synthesis and Anticonvulsant Activity of 2-(2-Phenoxy) phenyl- 1,3,4-oxadiazole Derivatives. Iran J Pharm Res (2013) 0.88

Association between Helicobacter pylori Infection in gastric cancer, ulcers and gastritis in Iranian patients. Helicobacter (2004) 0.88

Synthesis and cytotoxic evaluation of some new[1,3]dioxolo[4,5-g]chromen-8-one derivatives. Daru (2014) 0.88

N,N-Dimethyl-propane-1,2-diaminium bis-(6-carb-oxy-pyridine-2-carboxyl-ate) monohydrate. Acta Crystallogr Sect E Struct Rep Online (2011) 0.88

Development and validation of a rapid HPLC method for simultaneous determination of tramadol, and its two main metabolites in human plasma. J Chromatogr B Analyt Technol Biomed Life Sci (2005) 0.87

5,6-Dimethoxybenzofuran-3-one derivatives: a novel series of dual Acetylcholinesterase/Butyrylcholinesterase inhibitors bearing benzyl pyridinium moiety. Daru (2013) 0.87

Synthesis and docking studies of new 1,4-dihydropyridines containing 4-(5)-Chloro-2-ethyl-5-(4)-imidazolyl substituent as novel calcium channel agonist. Arch Pharm Res (2009) 0.87

Yeast of the oral cavity is the reservoir of Heliobacter pylori. J Oral Pathol Med (2008) 0.87

Synthesis, QSAR and calcium channel antagonist activity of new 1,4-dihydropyridine derivatives containing 1-methyl-4,5-dichloroimidazolyl substituents. Arch Pharm (Weinheim) (2007) 0.87

Cytotoxic activity evaluation and QSAR study of chromene-based chalcones. Arch Pharm Res (2012) 0.87

Synthesis and antibacterial activity of new 7-piperazinyl-quinolones containing a functionalized 2-(furan-3-yl)ethyl moiety. Arch Pharm (Weinheim) (2007) 0.87

Medicinal plants in the treatment of Helicobacter pylori infections. Pharm Biol (2014) 0.86

Accurate quantification of endogenous androgenic steroids in cattle's meat by gas chromatography mass spectrometry using a surrogate analyte approach. Anal Chim Acta (2008) 0.86

Lipophilic 4-imidazoly-1,4-dihydropyridines: synthesis, calcium channel antagonist activity and protection against pentylenetetrazole-induced seizure. Farmaco (2004) 0.86

2,3-Diamino-pyridinium 6-carb-oxy-pyridine-2-carboxyl-ate. Acta Crystallogr Sect E Struct Rep Online (2011) 0.86

Synthesis and Antimycobacterial Activity of 2-(Phenylthio) benzoylarylhydrazone Derivatives. Iran J Pharm Res (2011) 0.86

Synthesis, QSAR and calcium channel modulator activity of new hexahydroquinoline derivatives containing nitroimidazole. Chem Biol Drug Des (2007) 0.86

Synthesis and in vitro anti-leishmanial activity of 1-[5-(5-nitrofuran-2-yl)-1,3,4-thiadiazol-2-yl]- and 1-[5-(5-nitrothiophen-2-yl)-1,3,4-thiadiazol-2-yl]-4-aroylpiperazines. Bioorg Med Chem (2008) 0.85

Synthesis and Cytotoxicity Study of New Cyclopenta [b] quinoline-1,8-dione Derivatives. Iran J Pharm Res (2011) 0.85

Functionalized N(2-oxyiminoethyl) piperazinyl quinolones as new cytotoxic agents. J Pharm Pharm Sci (2007) 0.85

5-Nitroimidazole-based 1,3,4-thiadiazoles: heterocyclic analogs of metronidazole as anti-Helicobacter pylori agents. Arch Pharm (Weinheim) (2010) 0.85

Synthesis and in vitro antifungal and cytotoxicity evaluation of substituted 4,5-dihydronaphtho[1,2-d][1,2,3]thia(or selena)diazoles. Farmaco (2003) 0.85